Trump’s Big Announcement Shakes Indian Pharma Stocks

Trump’s Big Announcement Shakes Indian Pharma Stocks – May 2025

🔻 Indian Pharma Shares Crash:

• Reason: U.S. President Donald Trump signed an executive order to boost domestic drug manufacturing in the U.S.

• This raised concerns over possible restrictions on Indian pharmaceutical exports, leading to stock market jitters.

• Nifty Pharma Index dropped by 1.4%.

  • Lupin: fell over 3%

  • Aurobindo Pharma: fell over 3%

  • Cipla: dropped over 2%

  • Sun Pharma: down 1.9%

  • Biocon: slipped 0.3%

🎬 100% Duty on Foreign Films Threatened:

• Trump warned of imposing 100% tariffs on films made outside the U.S..

• He posted on TruthOut saying the American film industry is “dying”, and that other countries are offering incentives to lure studios away from the U.S.

📉 Stock Market Reaction:

• BSE Sensex dropped 100 points to 80,696.44

• NSE Nifty fell 40 points to 24,421

• Top losers: Titan, Sun Pharma, Reliance Industries, Kotak Bank

• Gainers: Mahindra & Mahindra, Airtel, Nestle, Hindustan Unilever, Tata Steel

This announcement isn’t just political—it could be a serious concern for Indian exporters and investors depending heavily on U.S. markets.

Have something to say? Post your comment